Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS - LC-MSMS of plasma DeoxyCeramide (m18:1/24:0)

ABSTRACT: Characterization of human plasma deoxyceramide m18:1/24:0 associated with type two diabetes in the Jackson Heart Study cohort.

INSTRUMENT(S): Orbitrap ID-X

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Clary Clish

PROVIDER: MSV000090113 | GNPS | Thu Aug 11 14:11:00 BST 2022

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

LC-MSMS of plasma DeoxyCeramide (m18:1/24:0)

Project description:Characterization of human plasma deoxyceramide m18:1/24:0 associated with type two diabetes in the Jackson Heart Study cohort.

2022-08-11 | MSV000090113 | MassIVE

Small RNA-sequencing of plasma exosome-enriched extracellular vesicles derived miRNAs from lactating mothers with type 1 diabetes and lactating healthy mothers

Project description:Previous studies have shown that the circulating miRNA signatures are altered in plasma-derived extracellular vesicles of individuals with type 1 diabetes. These alterations in the miRNA profile could serve as a potential biomarker applicable in clinical practice for monitoring disease status in lactating mothers with type 1 diabetes during the postpartum period. In the present study, we investigate the profiles of extracellular vesicle-derived miRNAs in circulation in a cohort of lactating mothers with and without type 1 diabetes.

2021-09-23 | E-MTAB-10458 | biostudies-arrayexpress

PPARɑ variant V227A reduces plasma triglycerides through enhanced lipoprotein lipolysis

Project description:Human single nucleotide variants in peroxisome proliferator-activated receptor-ɑ (PPARɑ) have been associated with beneficial metabolic phenotypes yet their physiologic impact is unclear. Here, we developed a mouse model of a human PPARɑ variant encoding a substitution of valine for alanine at position 227 (V227A) to explore the role of this variant on systemic metabolism. While the variant did not alter body mass or liver lipid accumulation, this variant reduced plasma triglycerides, consistent with human cohort observations. Gene expression analysis revealed that the variant enhances Ppara target gene expression in the liver in a manner consistent with PPARɑ synthetic agonist treatment. The variant increased hepatic transcript expression of Lpl, the predominant enzyme responsible for circulating triglyceride hydrolysis. Further characterization revealed that heart tissue from variant mice exhibited increased Lpl expression and triglyceride hydrolysis activity, indicating that the heart serves as a major mediator of circulating triglyceride clearance. These findings validate human observational studies and clarify the physiological impact of this variant on plasma triglycerides.

2025-05-01 | GSE288347 | GEO

Characterization of human plasma pregnancy-associated miRNAs at first trimester and their association with pregnancy complications [cohort 2]

Project description:To characterize the human plasma microtranscriptome profile at first trimester of pregnancy in presence or not of pregnancy complications, we sequenced microRNAs in plasma samples collected from pregnant women between the 6th and the 15th weeks of pregnancy as a replication cohort. We then performed differential expression analyses to assess the miRNA profile diffrences according to the presence of pregnancy complications or not (i.e. Gestational diabetes mellitus, Gestational hypertension or preeclampsia vs. normal pregnancies).

2022-11-03 | GSE216997 | GEO

miRNA sequencing profile of human plasma samples from healthy, diabetic, and gastroparesis patients

Project description:We report the high-throughput miRNA sequencing of plasma isolated from human patients with type 2 diabetes & gastroparesis, idiopathic gastroparesis alone, and healthy control patients.

2020-12-31 | GSE139577 | GEO

FIA plasma induces arthritis in naïve mice

Project description:Plasma collected from mice with FIA were pooled, and 0.3 ml was injected intravenously into 6-week-old naïve SJL mice on days 0 and 2. Synovial antigen array profiling of plasma from the arthritic recipient mice demonstrated autoreactive B-cell responses against peptides representing native fibrinogen and citrullinated fibrinogen, and further epitope spreading resulting in additional targeting of fibronectin, collagen type V, cartilage gp39, and clusterin.

2009-09-12 | GSE18024 | GEO

Association between lncRNAs in plasma exosomes and diabetic retinopathy

Project description:Long noncoding RNA (lncRNA) in plasma exosomes is a potential non-invasive diagnostic biomarker for diabetic retinopathy (DR). However, the changes in plasma exosomal lncRNAs and diagnostic relevance in patients with DR patients remain unclear. A case–control study with type 2 diabetes mellitus (T2DM) and patients with comorbid DR were enrolled, and their clinical information and blood samples were collected.

2022-09-06 | GSE212594 | GEO

Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes

Project description:Type 1 diabetes mellitus (T1DM) results from an autoimmune attack against the insulin-producing ß cells which leads to chronic hyperglycemia. Exosomes are lipid vesicles derived from cellular multivesicular bodies that are enriched in specific miRNAs, potentially providing a disease-specific diagnostic signature. To assess the value of exosome miRNAs as biomarkers for T1DM, miRNA expression in plasma-derived exosomes was measured. Nanoparticle tracking analysis and transmission electron microscopy confirmed the presence of plasma-derived exosomes (EXOs) isolated by differential centrifugation. Total RNA extracted from plasma-derived EXOs of 12 T1DM and 12 control subjects was hybridized onto Nanostring human v2 miRNA microarray array and expression data were analyzed on nSolver analysis software. We found 7 different miRNAs (1 up-regulated and 6 down-regulated), that were differentially expressed in T1DM. The selected candidate miRNAs were validated by qRT-PCR analysis of cohorts of 24 T1DM and 24 control subjects. Most of the deregulated miRNAs are involved in progression of T1DM. These findings highlight the potential of EXOs miRNA profiling in the diagnosis as well as new insights into the molecular mechanisms involved in T1DM.

2017-09-06 | GSE97123 | GEO

Plasma Cell Type Isolated EVs

Project description:Plasma Cell Type Isolated EVs

| PRJNA1064083 | ENA

microRNA sequencing of plasma exosomes from normal individuals, patients with type 2 diabetes.

Project description:To investigate the differences in microRNA expression in plasma exosomes among normal individuals, patients with type 2 diabetes, we employed Agilent microarray expression profiling as a discovery platform to detect changes in microRNA levels in different target populations.

2025-03-28 | GSE262614 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data